NVCT Annual EBIT
-$22.90 M
-$3.66 M-19.04%
31 December 2023
Summary:
As of January 23, 2025, NVCT annual earnings before interest & taxes is -$22.90 million, with the most recent change of -$3.66 million (-19.04%) on December 31, 2023. NVCT annual EBIT is now -77.58% below its all-time high of -$12.89 million, reached on December 31, 2021.NVCT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCT Quarterly EBIT
-$4.36 M
+$284.00 K+6.12%
30 September 2024
Summary:
As of January 23, 2025, NVCT quarterly earnings before interest & taxes is -$4.36 million, with the most recent change of +$284.00 thousand (+6.12%) on September 30, 2024. Over the past year, it has increased by +$1.80 million (+29.21%). NVCT quarterly EBIT is now -18852.17% below its all-time high of -$23.00 thousand, reached on March 31, 2021.NVCT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCT TTM EBIT
-$20.26 M
+$1.80 M+8.15%
30 September 2024
Summary:
As of January 23, 2025, NVCT TTM earnings before interest & taxes is -$20.26 million, with the most recent change of +$1.80 million (+8.15%) on September 30, 2024. Over the past year, it has increased by +$2.54 million (+11.16%). NVCT TTM EBIT is now -88004.35% below its all-time high of -$23.00 thousand, reached on March 31, 2021.NVCT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.0% | +29.2% | +11.2% |
| 3 y3 years | - | +29.2% | +11.2% |
| 5 y5 years | - | +29.2% | +11.2% |
NVCT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -77.6% | at low | -92.5% | +36.5% | -57.2% | +12.6% |
| 5 y | 5-year | -77.6% | at low | <-9999.0% | +36.5% | <-9999.0% | +12.6% |
| alltime | all time | -77.6% | at low | <-9999.0% | +36.5% | <-9999.0% | +12.6% |
Nuvectis Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.36 M(-6.1%) | -$20.26 M(-8.2%) |
| June 2024 | - | -$4.64 M(+5.6%) | -$22.06 M(-4.9%) |
| Mar 2024 | - | -$4.40 M(-36.0%) | -$23.19 M(+1.3%) |
| Dec 2023 | -$22.90 M(+19.0%) | -$6.87 M(+11.5%) | -$22.90 M(+0.4%) |
| Sept 2023 | - | -$6.16 M(+6.7%) | -$22.81 M(+1.0%) |
| June 2023 | - | -$5.77 M(+40.7%) | -$22.59 M(+10.8%) |
| Mar 2023 | - | -$4.10 M(-39.5%) | -$20.39 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$19.23 M(+49.2%) | -$6.78 M(+14.1%) | -$19.23 M(+30.7%) |
| Sept 2022 | - | -$5.94 M(+66.2%) | -$14.72 M(+9.4%) |
| June 2022 | - | -$3.57 M(+21.3%) | -$13.45 M(-15.0%) |
| Mar 2022 | - | -$2.94 M(+30.0%) | -$15.82 M(+22.7%) |
| Dec 2021 | -$12.89 M | -$2.27 M(-51.5%) | -$12.89 M(+21.3%) |
| Sept 2021 | - | -$4.67 M(-21.4%) | -$10.63 M(+78.3%) |
| June 2021 | - | -$5.94 M(>+9900.0%) | -$5.96 M(>+9900.0%) |
| Mar 2021 | - | -$23.00 K | -$23.00 K |
FAQ
- What is Nuvectis Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Nuvectis Pharma?
- What is Nuvectis Pharma annual EBIT year-on-year change?
- What is Nuvectis Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly EBIT year-on-year change?
- What is Nuvectis Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Nuvectis Pharma?
- What is Nuvectis Pharma TTM EBIT year-on-year change?
What is Nuvectis Pharma annual earnings before interest & taxes?
The current annual EBIT of NVCT is -$22.90 M
What is the all time high annual EBIT for Nuvectis Pharma?
Nuvectis Pharma all-time high annual earnings before interest & taxes is -$12.89 M
What is Nuvectis Pharma annual EBIT year-on-year change?
Over the past year, NVCT annual earnings before interest & taxes has changed by -$3.66 M (-19.04%)
What is Nuvectis Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of NVCT is -$4.36 M
What is the all time high quarterly EBIT for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly earnings before interest & taxes is -$23.00 K
What is Nuvectis Pharma quarterly EBIT year-on-year change?
Over the past year, NVCT quarterly earnings before interest & taxes has changed by +$1.80 M (+29.21%)
What is Nuvectis Pharma TTM earnings before interest & taxes?
The current TTM EBIT of NVCT is -$20.26 M
What is the all time high TTM EBIT for Nuvectis Pharma?
Nuvectis Pharma all-time high TTM earnings before interest & taxes is -$23.00 K
What is Nuvectis Pharma TTM EBIT year-on-year change?
Over the past year, NVCT TTM earnings before interest & taxes has changed by +$2.54 M (+11.16%)